Pancreatic Cancer Research

ResearcherKeio UniversityNo recent work listed

Hiroaki Taniguchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0494-5290; OpenAlex author ID A5050211720. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Knockdown of 15-bp Deletion-Type v-raf Murine Sarcoma Viral Oncogene Homolog B1 mRNA in Pancreatic Ductal Adenocarcinoma Cells Repressed Cell Growth In Vitro a… Co-author DOI 10.3390/cancers14133162↗
  2. PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer. Last author DOI 10.1002/2211-5463.12519↗
  3. Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice. First author DOI 10.1093/carcin/bgx040↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohzoh Imai · 2 shared papers, 2017–2018 · strength 0.22
  2. Chiharu Moriya · 2 shared papers, 2017–2018 · strength 0.22
  3. Atsushi Satō · 1 shared paper, 2022 · strength 0.19
  4. Jiaxuan Song · 1 shared paper, 2022 · strength 0.19
  5. Kumiko Ui‐Tei · 1 shared paper, 2022 · strength 0.19
  6. Kazunori Kataoka · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.